BEAUVERIOLIDE III

ID: ALA409855

Max Phase: Preclinical

Molecular Formula: C27H41N3O5

Molecular Weight: 487.64

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Beauveriolide III
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CCCC[C@H](C)[C@@H]1CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@H]([C@@H](C)CC)C(=O)O1

    Standard InChI:  InChI=1S/C27H41N3O5/c1-6-8-12-18(4)22-16-23(31)29-21(15-20-13-10-9-11-14-20)26(33)28-19(5)25(32)30-24(17(3)7-2)27(34)35-22/h9-11,13-14,17-19,21-22,24H,6-8,12,15-16H2,1-5H3,(H,28,33)(H,29,31)(H,30,32)/t17-,18-,19-,21-,22-,24+/m0/s1

    Standard InChI Key:  VEELKRGSLCNVAR-QVZGIDAOSA-N

    Associated Targets(Human)

    Acyl coenzyme A:cholesterol acyltransferase 1 857 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Acyl coenzyme A:cholesterol acyltransferase 2 288 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Acyl coenzyme A:cholesterol acyltransferase 1 295 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Sterol O-acyltransferase 2 51 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Sterol O-acyltransferase 1 51 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 487.64Molecular Weight (Monoisotopic): 487.3046AlogP: 2.89#Rotatable Bonds: 8
    Polar Surface Area: 113.60Molecular Species: NEUTRALHBA: 5HBD: 3
    #RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 10.92CX Basic pKa: CX LogP: 3.88CX LogD: 3.88
    Aromatic Rings: 1Heavy Atoms: 35QED Weighted: 0.49Np Likeness Score: 1.81

    References

    1. Nagai K, Doi T, Ohshiro T, Sunazuka T, Tomoda H, Takahashi T, Omura S..  (2008)  Synthesis and biological evaluation of a focused library of beauveriolides.,  18  (15): [PMID:18620856] [10.1016/j.bmcl.2008.06.054]
    2. Doi T, Muraoka T, Ohshiro T, Matsuda D, Yoshida M, Takahashi T, Omura S, Tomoda H..  (2012)  Conformationally restricted analog and biotin-labeled probe based on beauveriolide III.,  22  (1): [PMID:22079027] [10.1016/j.bmcl.2011.10.045]
    3.  (2014)  Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases, 
    4.  (2015)  Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease, 
    5. Kapojos MM, Abdjul DB, Yamazaki H, Ohshiro T, Rotinsulu H, Wewengkang DS, Sumilat DA, Tomoda H, Namikoshi M, Uchida R..  (2018)  Callyspongiamides A and B, sterol O-acyltransferase inhibitors, from the Indonesian marine sponge Callyspongia sp.,  28  (10): [PMID:29631961] [10.1016/j.bmcl.2018.03.077]
    6. Bhattacharjee P, Rutland N, Iyer MR..  (2022)  Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential.,  65  (24.0): [PMID:36473091] [10.1021/acs.jmedchem.2c01265]